Welcome to the CEO Roundtable on Cancer Web Site.


The mission of the CEO Roundtable on Cancer is to make continual progress toward the elimination of cancer as a personal disease and public health problem. Members of the CEO Roundtable collaboratively work to develop and implement initiatives that reduce the risk of cancer, enable early diagnosis, facilitate better access to best-available treatments, and hasten the discovery of novel and more effective diagnostic tools and anti-cancer therapies.

"Ultimately, we know that as much as has been done, there is a lot of need for new treatments… and new hope. The Life Sciences Consortium is a powerful group that we can leverage. If companies and organizations come together in a collaborative way, then we can move the ball down the field a lot faster on oncology research."

Christopher A. Viehbacher
Chairman, CEO Roundtable on Cancer

Learn more about the
LEADERSHIP TEAM
  • Christopher A. ViehbacherChristopher A. Viehbacher
  • William C. WeldonWilliam C. Weldon
  • Robert A. IngramRobert A. Ingram
  • Martin J. Murphy, Ph.D., DMedScMartin J. Murphy, Ph.D., DMedSc
  • Mace Rothenberg, M.D.Mace Rothenberg, M.D.
  • Gregory A. Curt, M.D.Gregory A. Curt, M.D.
  • Judy O'HaganJudy O'Hagan
  • John N. DornanJohn N. Dornan
TASK FORCES:

The Gold Standard is a workplace-based program that focuses on lowering the risk of cancer, detecting it early when outcomes are more likely to be favorable, and ensuring access to quality care. Visit Website

The Life Sciences Consortium (LSC) brings together oncology pharmaceutical / biotechnology companies who work to remove roadblocks and find new ways to accelerate discovery and development of new therapies for all cancer patients. Visit Website

The Project Data Sphere platform provides one place where the research community can broadly share, integrate and analyze historical, patient-level, comparator-arm data from academic and industry phase III cancer clinical trials. Visit Website